October 17, 2024
Founding CEO Thomas Ybert transitions to Chief Scientific Officer role to underscore company’s ongoing commitment to scientific discovery and innovation PARIS and DALY CITY, Calif. – DNA Script, a leader in enzymatic DNA synthesis, today announced the appointment of Marc Montserrat as its new Chief Executive Officer. In addition, founding CEO Thomas Ybert, PhD, has transitioned to a new Chief Scientific Officer role, where he will continue to [...]
October 17, 2024
Biognosys’ proprietary P2 Plasma Enrichment System enables plasma proteome profiling with unprecedented depth and throughput, both as contract research and in-house via licensing By offering the combination of NULISA™ affinity-based assays and TrueDiscovery® mass spectrometry-based plasma profiling with P2 Plasma Enrichment, Biognosys offers the industry’s most comprehensive solutions for plasma proteomics Spectronaut® workflows for high-performance computing environments, [...]
DeNovix Releases Higher Magnification CellDrop Models
October 17, 2024
DeNovix Releases Higher Magnification CellDrop Models Optimized for Yeast, Stem Cells and Other Small Cells WILMINGTON, DE – DeNovix announces the expansion of the CellDrop Automated Cell Counter range with the commercial release of two new models, the CellDrop FLxi and CellDrop BFx. The new models include higher magnification optics designed for the quantification and [...]
DeNovix Releases New Eight Channel Spectrophotometer
October 17, 2024
WILMINGTON, DE – DeNovix introduces the DS-8X Eight Channel Spectrophotometer, a new addition to the DS-Series Quantification Range. The DS-8X is designed to equip labs with higher throughput, high performance, full spectrum 1 µL UV-Vis measurements (190 – 840 nm) for DNA, RNA and protein quantification. Based on the award-winning DS-11 technology, DS-Series instruments offer [...]
October 17, 2024
Research Triangle Park, NC – Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of research-grade IsoTag™ AAV reagent, for the purification of adeno associated viral vectors (AAV). The research-grade IsoTag™ AAV reagent marks a significant advancement from its prototype grade. It maintains the same non-chromatographic purification capabilities, but now provides [...]
PHI appoints Anders Månsson as new CEO
October 17, 2024
The board of Phase Holographic Imaging (PHI) has today appointed Anders Månsson as the new CEO of PHI as of November 1, 2024. The current CEO, Patrik Eschricht, will remain in his role until November 1, 2024, and ensure a smooth handover to Anders Månsson. Goran Dubravčić, Chairman of the Board, says: “I and the [...]
Nuclera closes $75 million USD financing
October 16, 2024
Series C round led by Elevage Medical Technologies Funding will accelerate the commercialization of Nuclera’s eProtein Discovery platform, to optimize protein expression and purification workflows within research labs globally Cambridge, UK, and Boston MA, USA: Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, today announced it has completed a [...]
Bio X Cell Announces Board of Director Appointments
October 16, 2024
A Leading Producer of Monoclonal Antibodies LEBANON, N.H. -- Bio X Cell, LLC ("BXC" or the "Company"), the world's leading producer of monoclonal antibodies for pre-clinical in vivo research applications, is pleased to announce the appointments of Alan Hirzel and Kevin Ballinger to its Board of Directors. "We are thrilled to welcome Alan Hirzel to the board alongside Kevin Ballinger, who joined earlier this [...]
Pillar Biosciences Announces Expansion of NGS Commercial Partnership with Illumina
October 16, 2024
Enables content for newly launched Illumina MiSeq™ i100 and expands Illumina oncology panel portfolio to include targeted liquid biopsy panels NATICK, Mass. -- Pillar Biosciences, Inc., the leader in Decision Medicine™, has today announced an expansion of their existing partnership with Illumina, through which a broader portfolio of Pillar's oncoReveal™ NGS panels will now be offered directly by Illumina. [...]
October 16, 2024
Univercells Technologies by Donaldson introduces the scale-X nexo bioreactor - offering a 0.5 m² growth surface, designed for efficient cell culture process development across multiple modalities. Nivelles, Belgium – Univercells Technologies by Donaldson, a global leader in bioprocessing technologies, proudly announces the launch of its latest innovation, the scale-X™ nexo bioreactor. This cutting-edge addition to the [...]

